When I was a kid, I was always kind of a rebel. I didn’t respond well to authority. I wanted to be as free as…
Fatty liver disease
FATTY LIVER DISEASE
NewsApproval of Kayshild, sold in US as Wegovy, urged in EU for treating MASH
A committee of the European Medicines Agency (EMA) has recommended that Kayshild (semaglutide), marketed in the U.S. and Canada as Wegovy, be approved in…
FATTY LIVER DISEASE
ColumnsWhile you were asleep: Nighttime may affect your liver more than you think
A few years ago, I bought myself a fitness watch. As I worked to rebuild my health after being diagnosed with metabolic dysfunction-associated steatohepatitis…
FATTY LIVER DISEASE
NewsCombination of aerobic, resistance exercise best for reducing liver fat
A combination of aerobic exercise and resistance exercise is most effective for reducing liver fat, according to a review of data from appropriately controlled clinical…
FATTY LIVER DISEASE
ColumnsGetting ahead of concerns about fatty liver disease in children
Growing up, I was very much a daddy’s girl. My dad had a lively personality that helped him make instant friends wherever he went, sometimes…
FATTY LIVER DISEASE
ColumnsThink smoking only affects your lungs? Your liver would like a word.
When a new year rolls around, many of us naturally turn our attention to health. I’ve made enough resolutions over the years to know that…
FATTY LIVER DISEASE
NewsMadrigal acquires ervogastat to help boost MASH treatment options
Madrigal Pharmaceuticals, the maker of Rezdiffra (resmetiron), has acquired three new experimental treatments for metabolic dysfunction-associated steatohepatitis (MASH), a severe form of fatty…
FATTY LIVER DISEASE
ColumnsCould GLP-1 medications be the future of fatty liver disease treatment?
Humans tend to love animals — especially the fuzzy, cuddly kind. I’m no exception. Anyone who knows me knows my devotion to my three cats:…
FATTY LIVER DISEASE
NewsPemvidutide advances toward Phase 3 after strong MASH fibrosis results
About one year of treatment with Altimmune’s experimental therapy pemvidutide led to reductions in noninvasive markers of liver scarring (fibrosis) in people with metabolic…
LIVER DISEASE
NewsTop 10 Liver Disease News stories of 2025
Throughout 2025, the team at Liver Disease News has reported on the latest research and advances in care related to various rare and non-rare liver…
Recent Posts
- One of my superpowers for MASH is defiance in the name of compliance
- Canada approves Livmarli oral tablets for Alagille itching
- New experimental therapy enters early human testing for hepatitis B
- Risk of PSC recurrence 4 times higher with living donor transplant: Study
- Early detection highlighted in this year’s Rare Liver Diseases Month